Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for phosphodiesterase type- 3 inhibitor
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- Drug target sets for approved compounds
- Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Affymetrix]
Most Relevant Literature
- Treatment of Cardiovascular Dysfunction with PDE3-Inhibitors in Moderate and Severe Hypothermia-Effe…
- PDE3-inhibitor enoximone prevented mechanical ventilation in patients with SARS-CoV-2 pneumonia.
- PDE3 Inhibitors Repurposed as Treatments for Age-Related Cognitive Impairment.
- K-134, a phosphodiesterase 3 inhibitor, prevents brain damage by inhibiting thrombus formation in a …
- Phosphodiesterase-3 inhibitor].
Most Relevant Clinical Trials
- Phosphodiesterase Inhibitors in Glaucoma Study (PhiGS)
- Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy…
- The Role of Phosphodiesterase Inhibitors in Incretin Secretion
- The Phosphodiesterase Inhibitor Pentoxifylline as an Adjuvant in Treatment of Negative Symptoms in C…
- Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Dis…
